Voyager Technologies, Inc./TX
VOYG NYSE Guided Missiles & Space Vehicles & Parts Financials FY2023βFY2025
What Voyager Technologies, Inc./TX does
No business description yet.
- Legal name
- Voyager Technologies, Inc./TX
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 10, 2026
- Accession Β· CIK
- 0001628280-26-016543
0001788060
Revenue and margins
Voyager Technologies, Inc./TX had $166M of revenue in fiscal 2025, up 15.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$206M in fiscal 2025, β123.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Voyager Technologies, Inc./TX returned β to shareholders in fiscal 2025. The diluted share count rose 215.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Voyager Technologies, Inc./TX can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $30.3M | $55.9M | $491M |
| Interest coverage | β1.3x | β4.0x | β15.9x |
| Current ratio | β | 1.2x | 4.4x |
| Quick ratio | β | 1.1x | 4.3x |
| Total assets | β | $248M | $1.1B |
| Total liabilities | β | $188M | $621M |
| Shareholders' equity | β$92.6M | β$69.7M | $384M |
| Net debt (β = net cash) | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 5 | 3 / 8 |
| Accruals ratio | β | β14.8% | β6.8% |
| Altman Z'' | β | β5.03 | 1.56 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $136M | $144M | $166M |
| Gross profit | $27.8M | $34.9M | $29.9M |
| Research and development | $18.5M | $13.0M | $19.0M |
| Operating income | β$14.2M | β$48.4M | β$108M |
| Interest expense | $10.6M | $12.0M | $6.8M |
| Pretax income | β$24.9M | β$67.3M | β$113M |
| Income tax | $0.3M | β$1.7M | β$0.4M |
| Net income | β$25.4M | β$62.1M | β$105M |
| Net income to common | β$43.3M | β$83.9M | β$116M |
| Diluted EPS | β$3.65 | β$7.01 | β$2.89 |
| Diluted shares | 0.01B | 0.01B | 0.04B |
| Cash flow | |||
| Cash from operations | β$15.4M | β$25.5M | β$60.9M |
| Capital expenditure | $17.2M | $82.7M | $145M |
| Free cash flow | β$32.6M | β$108M | β$206M |
| Depreciation and amortization | $10.3M | $13.6M | $13.4M |
| Stock-based compensation | $2.7M | $3.8M | $18.9M |
| Acquisitions | β$2.1M | $0.0M | $152M |
| Balance sheet | |||
| Cash and short-term investments | $30.3M | $55.9M | $491M |
| Current assets | β | $102M | $581M |
| Current liabilities | β | $87.4M | $133M |
| Inventory | β | $1.5M | $3.8M |
| Property and equipment, net | β | $49.4M | $164M |
| Goodwill | β | $46.5M | $158M |
| Intangible assets | β | $34.7M | $99.0M |
| Total assets | β | $248M | $1.1B |
| Total liabilities | β | $188M | $621M |
| Shareholders' equity | β$92.6M | β$69.7M | $384M |
| Margins | |||
| Gross margin | 20.4% | 24.2% | 18.0% |
| Operating margin | β10.4% | β33.6% | β65.2% |
| EBITDA margin | β2.9% | β24.2% | β57.1% |
| Net margin | β18.7% | β43.1% | β63.0% |
| FCF margin | β24.0% | β75.0% | β123.6% |
| Returns | |||
| Return on capital employed | β | β30.2% | β11.8% |
| Return on equity | β | β | β66.8% |
| Return on assets | β | β25.1% | β16.1% |
| Return on tangible equity | β | β | β91.3% |
| Growth | |||
| Revenue growth | β | 6.0% | 15.4% |
| Share count change | β | β0.1% | 215.5% |
| Financial health | |||
| Interest coverage | β1.3x | β4.0x | β15.9x |
| Current ratio | β | 1.2x | 4.4x |
| Quick ratio | β | 1.1x | 4.3x |
| Capital allocation | |||
| Capex / revenue | 12.6% | 57.4% | 86.9% |
| Stock comp / revenue | 2.0% | 2.6% | 11.4% |
| Quality scores | |||
| Piotroski F-score | β | β | 3.0 |
| Altman Z'' | β | β5.0 | 1.6 |
| Accruals ratio | β | β14.8% | β6.8% |
Source: SEC EDGAR XBRL filings (CIK 0001788060). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.